"Ocular Manifestations of COVID-19: An Update and A Review of Current Literature"

Abstract

Prevention also identified the causative agent as Sars-CoV-2 following a more extensive study using nasopharyngeal swabs [3,4]. As of the 28 of December 2021, there were 252,976,252 documented cases worldwide, and 5,099,860 reported deaths [5]. The death rate varies by country and ‘appears’ to be low in those with effective public health and primary healthcare systems [6]. The SARS-CoV-2 virus is transmitted mostly by respiratory droplets during close face-to-face contact, with an average time interval of five days between exposure and symptom onset [7]. Initial reports from China indicated a high incidence of symptoms, with fever accounting for 98% of cases, cough accounting for 77%, and myalgia accounting for 44% of patients evaluated [8]. However, the literature is beginning to reveal a more nuanced semiology [9¬-16]. Along with the cardinal signs of COVID-19 (fever (88-100%), cough (68-85%), and sputum (23-41%)), several other signs have been reported [9-16]: anorexia (84%), asthenia (70-80%), ABSTRACT Coronavirus disease 2019 (COVID-19) was declared a pandemic by the World Health Organization (WHO) in March 2020. It was caused by the highly pathogenic SARS-Cov-2 virus. Although the majority of its clinical manifestations are associated with airway involvement, extrapulmonary damage does occur in some situations. In light of the above discussion, this study of the literature tries to identify the ophthalmological disorders produced by infection with the new coronavirus. Although ocular symptoms do not correspond to the disease’s standard clinical presentation, there are reports of some ophthalmological alterations in COVID-19 individuals, the most prevalent of which is conjunctivitis.